Obstructive sleep apnea and hypertension
There is growing evidence of a causal relationship between obstructive sleep apnea (OSA) and hypertension. Untreated OSA may have direct and deleterious effects on cardiovascular function and structure through several mechanisms, including sympathetic activation, oxidative stress, inflammation, and endothelial dysfunction. OSA may contribute to or augment elevated blood pressure levels in a large proportion of the hypertensive patient population. It is important to consider OSA in the differential diagnosis of hypertensive patients who are obese. OSA should be especially considered in those hypertensive patients who respond poorly to combination therapy with antihypertensive medications.
KeywordsObstructive Sleep Apnea Sleep Apnea Continuous Positive Airway Pressure Obstructive Sleep Apnea Syndrome Respir Crit
Unable to display preview. Download preview PDF.
References and Recommended Reading
- 9.Nieto FJ, Young TB, Bonnie KL, et al. for the Sleep Heart Health Study: Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. JAMA 2000, 283:1829–1836. This study has demonstrated a dose-response association between sleep-disordered breathing at baseline and the presence of de novo hypertension 4 years later. These findings provide strong evidence for a causal relationship between OSA and hypertension.PubMedCrossRefGoogle Scholar
- 10.Haas DC, Foster GL, Nieto FJ, et al.: Age-dependent associations between sleep-disordered breathing and hypertension: importance of discriminating between systolic/ diastolic hypertension and isolated systolic hypertension in the Sleep Heart Health Study. Circulation 2005, 111:614–621. This study has shown that OSA is independently associated with hypertension in the middle-aged subjects but not in the elderly. Thus, the link between sleep-disordered breathing and hypertension may be attenuated by aging.PubMedCrossRefGoogle Scholar
- 14.Drager LF, Bortolotto LA, Lorenzi MC, et al.: Early signs of atherosclerosis in obstructive sleep apnea. Am J Respir Crit Care 172:613–618.Google Scholar
- 26.Parati G, Di Rienzo M, Ulian L, et al.: Clinical relevance blood pressure variability. J Hypertens 1998, 16:S25-S33.Google Scholar
- 31.Phillips BG, Kato M, Narkiewicz K, et al.: Increases in leptin levels, sympathetic drive, and weight gain in obstructive sleep apnea. Am J Physiol 2000, 279:H234-H237.Google Scholar
- 44.Becker HF, Jerrentrup A, Ploch T, et al.: Effect of nasal continuous positive airway pressure treatment on blood pressure in patients with obstructive sleep apnea. Circulation 2003, 107:68–73. This controlled study has demonstrated that effective CPAP treatment leads to a substantial blood pressure reduction in OSA patients. Subtherapeutic CPAP, despite a 50% reduction in the AHI, did not decrease blood pressure.PubMedCrossRefGoogle Scholar
- 45.Narkiewicz K, Kato M, Phillips BG, et al.: Nocturnal continuous positive airway pressure decreases daytime sympathetic traffic in obstructive sleep apnea. Circulation 1999, 100:2332–2335. Long-term CPAP treatment decreases sympathetic traffic in otherwise healthy OSA patients. Thus, CPAP may provide beneficial effects beyond better blood pressure control.PubMedGoogle Scholar
- 46.Babu AR, Herdegen J, Fogelfeld L, et al.: Type 2 diabetes, glycemic control, and continuous positive airway pressure in obstructive sleep apnea. Arch Intern Med 2005, 165:447–452. Using a 72-hour continuous glucose monitoring system, the authors have demonstrated that CPAP treatment improves glycemic control in type 2 diabetics.PubMedCrossRefGoogle Scholar
- 48.Buchwald H, Avidor Y, Braunwald E, et al.: Bariatric surgery. A systematic review and meta analysis. JAMA 2004, 292:1724–1737. A systematic review and meta-analysis of articles on bariatric surgery showing that up to 85% of OSA patients experience complete resolution of sleep-disordered breathing.PubMedCrossRefGoogle Scholar